Research and development strategies of new Chinese medicines based on new regulations / 中国中药杂志
China Journal of Chinese Materia Medica
;
(24): 3150-3155, 2021.
Article
in Chinese
| WPRIM
| ID: wpr-888055
ABSTRACT
In recent years, only a small number of new Chinese medicines have been approved for marketing, which has embodied the bottleneck in the development of the Chinese medicine industry. To tackle this problem, the National Medical Products Administration has issued a series of regulations and technical requirements. In the context of new regulations, this study deeply explored the research and development strategies of new Chinese medicines under the guidance of the new classification of drug registration, and discussed the key technical issues in the research and development.
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Research
/
Drugs, Chinese Herbal
/
Pharmaceutical Preparations
/
China
/
Medicine, Chinese Traditional
Type of study:
Diagnostic study
Country/Region as subject:
Asia
Language:
Chinese
Journal:
China Journal of Chinese Materia Medica
Year:
2021
Type:
Article
Similar
MEDLINE
...
LILACS
LIS